Biopharma deals get smaller and earlier – Nature Biotechnology
Nature Biotechnology, Published online: 13 December 2024; doi:10.1038/s41587-024-02506-7
Merger and acquisition activity is at a seven-year low in 2024 as buyers digest prior deals and US election jitters delayed further spending. Expect a pick-up in 2025.
